Trastuzumab--mechanism of action and use in clinical practice

N Engl J Med. 2007 Jul 5;357(1):39-51. doi: 10.1056/NEJMra043186.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Chemotherapy, Adjuvant
  • ErbB Receptors / metabolism
  • Humans
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / drug effects*
  • Receptor, ErbB-2 / immunology
  • Receptor, ErbB-2 / metabolism
  • Signal Transduction / drug effects
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Receptor, ErbB-2
  • Trastuzumab